American Portfolios Advisors Intellia Therapeutics, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 14,450 shares of NTLA stock, worth $240,592. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,450
Holding current value
$240,592
% of portfolio
0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$53.92 - $71.7 $779,144 - $1.04 Million
14,450 New
14,450 $809 Million
Q2 2022

Mar 20, 2023
BUY
$38.49 - $76.21 $26,250 - $51,975
682 Added 4.72%
15,132 $783 Million
Q1 2022

Mar 21, 2023
BUY
$58.27 - $118.99 $64,155 - $131,007
1,101 Added 7.62%
15,551 $1.13 Billion
Q4 2021

Mar 21, 2023
BUY
$100.76 - $138.36 $294,319 - $404,149
2,921 Added 20.21%
17,371 $2.05 Billion
Q3 2021

Mar 22, 2023
BUY
$132.37 - $176.78 $265,534 - $354,620
2,006 Added 13.88%
16,456 $2.21 Billion
Q2 2021

Mar 22, 2023
BUY
$60.88 - $161.91 $227,934 - $606,191
3,744 Added 25.91%
18,194 $2.95 Billion
Q1 2021

Mar 22, 2023
BUY
$46.59 - $83.68 $641,218 - $1.15 Million
13,763 Added 95.25%
28,213 $2.26 Billion
Q4 2020

Mar 22, 2023
BUY
$18.83 - $63.53 $166,701 - $562,431
8,853 Added 61.27%
23,303 $1.27 Billion
Q3 2020

Mar 22, 2023
SELL
$17.47 - $24.93 $9,014 - $12,863
-516 Reduced 3.57%
13,934 $277 Million
Q2 2020

Mar 24, 2023
BUY
$11.14 - $22.87 $52,669 - $108,129
4,728 Added 337.71%
6,128 $129 Million
Q1 2020

Mar 24, 2023
SELL
$9.44 - $15.58 $123,192 - $203,319
-13,050 Reduced 90.31%
1,400 $17.1 Million
Q4 2019

Mar 24, 2023
SELL
$10.43 - $17.67 $146,969 - $248,987
-14,091 Reduced 97.52%
359 $5.27 Million
Q3 2019

Mar 24, 2023
SELL
$13.07 - $18.51 $1,307 - $1,851
-100 Reduced 21.79%
359 $4.79 Million
Q2 2019

Mar 24, 2023
SELL
$13.88 - $18.41 $194,195 - $257,574
-13,991 Reduced 96.82%
459 $7.51 Million
Q4 2018

Mar 24, 2023
SELL
$11.39 - $27.13 $1,480 - $3,526
-130 Reduced 22.07%
459 $6.27 Million
Q3 2018

Mar 24, 2023
SELL
$25.78 - $32.6 $357,336 - $451,868
-13,861 Reduced 95.92%
589 $16.9 Million
Q2 2018

Mar 24, 2023
BUY
$20.02 - $30.79 $9,289 - $14,286
464 Added 371.2%
589 $16.1 Million
Q1 2018

Mar 24, 2023
SELL
$19.43 - $34.95 $278,334 - $500,658
-14,325 Reduced 99.13%
125 $2.64 Million

Others Institutions Holding NTLA

# of Institutions
318
Shares Held
89.3M
Call Options Held
668K
Put Options Held
865K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.27B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email